Dr. Miver Erem Tokuş
NeurosurgeryVerified
- 24+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Brain Surgery
Pituitary tumor surgery
What pituitary tumor surgery involves, how endoscopic transsphenoidal removal decompresses the optic chiasm and clears adenomas, what clinical evidence shows regarding hormone control, approximate costs in Turkey compared with the UK, US and Germany, realistic before-and-after expectations, hospital recovery, potential risks and how to evaluate a specialised skull-base neurosurgical team.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Brain Surgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Pituitary Tumor Surgery
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Pituitary tumor surgery in Turkey: what it is and how it works
Pituitary tumor surgery is a specialised neurosurgical intervention designed to remove abnormal tissue from the pituitary gland. Situated within a bony pocket called the sella turcica at the base of the skull, the pituitary gland governs essential hormone systems throughout the body. Directly above this gland sits the optic chiasm, where the optic nerves intersect. When a pituitary adenoma grows, it often presses upward against these visual pathways, resulting in peripheral vision loss, or disrupts the secretion of hormones, leading to conditions such as Cushing's disease, acromegaly, or hyperprolactinemia.
In modern neurosurgical hospitals in Turkey, the vast majority of these operations are carried out through the nasal passages using an endoscopic transsphenoidal approach. This minimally invasive route reaches the skull base without cranial incisions, brain retraction, or visible facial scarring. This clinical guide explains how the surgery is performed, what international medical evidence says about visual and endocrine recovery, approximate costs in Turkey compared with the UK, US, and Germany, and what aftercare entails. To explore related skull-base procedures, see our guide to neurosurgery treatments in Turkey.
How is endoscopic transsphenoidal surgery performed?
Endoscopic transsphenoidal pituitary tumor surgery follows a structured sequence managed jointly by an ENT skull-base surgeon and a neurosurgeon. The operation is performed under general anaesthesia with the patient's head stabilised in a cranial fixation frame. High-resolution magnetic resonance imaging (MRI) and computed tomography (CT) datasets are loaded into an optical neuronavigation system, providing real-time three-dimensional instrument tracking throughout the skull base.
The ENT surgeon first enters through both nostrils using rigid high-definition endoscopes. After gently displacing the nasal turbinates, an opening is created through the anterior wall of the sphenoid sinus. If a substantial opening into the cerebral spinal fluid space is anticipated, a vascularised nasoseptal mucosal flap is carefully mobilised and stored in the nasopharynx for later skull-base reconstruction. For details on the technical aspects of skull-base access, see our guide to transnasal resection of tumor.
Once the sphenoid cavity is opened, the neurosurgeon identifies the thin bony floor of the sella turcica, flanked by the optic canals and internal carotid arteries. Using precision micro-drills and delicate rongeurs, the sellar bone is opened and the dura is incised. The adenoma is removed systematically using micro-curettes and aspirators. Because adenoma tissue is typically softer than normal anterior pituitary gland tissue, surgeons distinguish and preserve the healthy gland. Angled endoscopes (30 and 45 degrees) allow inspection of suprasellar and lateral pockets. Finally, the skull base is sealed using multilayer dural substitutes, surgical sealant, or the nasoseptal flap to prevent fluid leakage. The entire procedure typically lasts two to three hours.
Does pituitary tumor surgery work: what does clinical evidence show?
Clinical studies and international neurosurgical guidelines demonstrate that transsphenoidal pituitary tumor surgery is highly effective, though success rates depend heavily on tumor size, invasiveness, and endocrine function:
- Visual decompression: For patients with visual field impairment caused by optic chiasm compression, surgical decompression achieves visual improvement or complete restoration in 80% to 90% of cases, provided optic nerve damage is not longstanding.
- Secretory microadenomas: In microadenomas (under 10 millimetres) producing ACTH (Cushing's disease) or growth hormone (acromegaly), complete biochemical remission is achieved in approximately 70% to 85% of cases.
- Macroadenomas: In larger non-functioning macroadenomas, complete gross resection is possible in roughly 60% to 75% of operations. However, if the tumor has invaded laterally into the cavernous sinus or encased the internal carotid artery, complete surgical clearance cannot be achieved safely. In such cases, intentional partial resection relieves pressure on the optic chiasm, and residual tissue is managed with medical therapy or targeted stereotactic radiotherapy.
- Prolactinomas: For prolactin-secreting tumours, medical management with dopamine agonists remains the first-line standard; surgery is reserved for patients intolerant to medication or whose tumours fail to shrink.
Pituitary tumor surgery cost in Turkey compared with the UK, US and Germany
The figures below outline approximate price ranges for pituitary tumor surgery across major medical travel destinations. These figures represent general price benchmarks rather than individual hospital quotes. Neurosurgical costs depend on tumor complexity, navigation requirements, operating time, and length of intensive care stay.
| Country | Approximate cost range |
|---|---|
| Turkey | €7,500 – €16,000 |
| United Kingdom | €18,000 – €35,000 |
| United States | €35,000 – €85,000 |
| Germany | €16,000 – €32,000 |
The overall pituitary tumor surgery price depends on several factors: whether the procedure is primary or a revision, whether a vascularised flap reconstruction is needed, and the duration of post-operative neuro-intensive care monitoring. In the UK and Germany, private neurosurgery is billed by individual consultant and bed fees, whereas pituitary tumor surgery in Turkey is typically packaged to include pre-operative 3T MRI, neuro-endocrinology evaluation, surgeon and anaesthetist fees, three to five hospital nights, pathology, and airport transfers.
Transsphenoidal surgery, craniotomy or stereotactic radiosurgery: which approach suits your tumor?
Neurosurgical teams evaluate each patient using high-resolution imaging to determine the most appropriate intervention. While endoscopic transsphenoidal resection is the standard approach for over 95% of pituitary adenomas, alternative modalities serve specific roles.
| Method | Best suited to | Typical limits |
|---|---|---|
| Endoscopic transsphenoidal surgery | Most pituitary adenomas, microadenomas, and macroadenomas with suprasellar extension | Cannot safely remove tumor tissue extending laterally beyond the cavernous carotid artery |
| Transcranial craniotomy (open surgery) | Rare giant adenomas with massive lateral or anterior subfrontal extension | Requires cranial opening and brain retraction; longer recovery and higher cosmetic impact |
| Stereotactic radiosurgery (Gamma Knife) | Small residual or recurrent tumor remnants in the cavernous sinus after resection | Does not provide rapid optic nerve decompression; hormone normalisation can take several years |
Most pituitary adenomas are accessed directly through the nostrils; learn more about endoscopic access in our overview of transnasal resection of tumor, or explore the wider range of neurosurgery treatments in Turkey.
Who is a suitable candidate for pituitary tumor removal?
Candidacy for surgery is established following visual perimetry testing, endocrine blood panels, and contrast-enhanced pituitary MRI. Suitable candidates include:
- Patients with non-functioning macroadenomas causing compression of the optic chiasm, visual acuity loss, or progressive visual field defects.
- Patients with ACTH-secreting adenomas (Cushing's disease) or GH-secreting adenomas (acromegaly) where surgery represents the definitive cure.
- Patients experiencing pituitary apoplexy—an acute infarction or haemorrhage into an existing adenoma causing sudden severe headache and rapid visual failure.
- Patients with expanding tumours that threaten adjacent cranial nerves despite medical observation.
Surgery is generally not recommended for asymptomatic micro-incidentalomas that show no growth and produce no hormone abnormalities; these are safely managed with periodic MRI monitoring. Likewise, prolactinomas responsive to cabergoline rarely require surgery, and patients with severe, uncorrected systemic illness may face unacceptable anaesthetic risks.
Before and after pituitary tumor surgery: what results should you expect?
Unlike aesthetic procedures, pituitary tumor surgery before and after outcomes are measured objectively through neuro-ophthalmic examinations, endocrine laboratory assays, and post-operative MRI scans. Photographs of facial appearance do not reflect surgical success, although resolution of facial puffiness in Cushing's disease or soft-tissue swelling in acromegaly becomes visible over subsequent months.
Patients who experienced dimming or tunnel vision frequently report improved visual clarity within days of decompression. Follow-up automated visual field testing at six to twelve weeks documents the extent of permanent recovery. Post-operative imaging performed around three months confirms the degree of tumor resection and establishes a baseline for future surveillance. Blood and saliva tests verify whether hormone hypersecretion has resolved or whether replacement hormones are needed.
Pituitary tumor surgery recovery and your hospital stay in Turkey
Planning pituitary tumor surgery recovery requires an understanding of hospital milestones and post-discharge restrictions. Patients typically spend three to five nights in hospital, beginning with one to two nights in a dedicated neuro-intensive care or high-dependency unit. During this period, nurses and endocrinologists closely track fluid intake, urinary output, and serum sodium levels every six to eight hours to detect diabetes insipidus—a temporary disruption in water regulation caused by posterior pituitary manipulation.
Before hospital discharge, morning cortisol levels are measured to ensure the adrenal system is functioning safely. When planning pituitary tumor surgery Turkey packages typically cover seven to ten days in the country. This timeline allows your ENT surgeon to inspect the nasal passages, remove temporary dissolvable packing, and confirm that there is no cerebrospinal fluid leakage before clearing you for air travel.
Once home, recovery requires strict adherence to skull-base precautions for four to six weeks:
- Do not blow your nose; sneeze with an open mouth to avoid sudden intracranial pressure spikes.
- Avoid heavy lifting (over five kilograms), strenuous straining, and bending forward at the waist.
- Use prescribed saline nasal sprays to keep the nasal mucosa clean and hydrated.
- Most patients return to desk-based work after three to four weeks, while vigorous sports and flying should wait until your six-week neurosurgical follow-up.
Risks and potential complications of pituitary tumor surgery
According to clinical data published by national health bodies including the UK National Health Service (NHS) and the American Association of Neurological Surgeons (AANS), transsphenoidal pituitary resection is safe when performed in specialised centres, carrying a mortality rate under 0.5%. However, serious risks exist:
- Cerebrospinal fluid (CSF) leak: Occurs in 2% to 5% of operations when the arachnoid membrane around the tumor is opened. Managed with multilayer reconstruction, temporary lumbar drainage, or occasionally revision repair.
- Diabetes insipidus: Temporary excess urination and thirst occur in 10% to 20% of patients due to transient vasopressin deficiency, easily managed with desmopressin (DDAVP). Permanent diabetes insipidus affects fewer than 2% to 4% of cases.
- Hypopituitarism: Damage to surrounding healthy pituitary tissue may reduce production of thyroid, adrenal, or sex hormones, requiring daily hormone replacement therapy.
- Meningitis: A rare secondary infection (under 1% to 2%) arising if an undetected CSF leak allows bacteria from the nasal cavity into the cranial space.
- Vascular injury: Injury to the internal carotid artery is an extremely rare skull-base complication (under 0.5%) avoided through continuous neuronavigation and micro-Doppler ultrasound monitoring.
- Sinus symptoms: Temporary nasal congestion, crusting, and reduced sense of smell are common and usually resolve within six to eight weeks.
How to choose a neurosurgical centre and red flags to watch for
Because pituitary surgery demands dual expertise in cranial neurosurgery and endoscopic skull-base rhinology, choosing an appropriately equipped medical facility is critical. Look for hospitals that feature a collaborative skull-base team where an experienced neurosurgeon and an ENT rhinologist operate together. The hospital must maintain an accredited neuro-intensive care unit, an active multidisciplinary pituitary board including endocrinologists and neuroradiologists, and on-site high-field 3T MRI and optical neuronavigation systems.
Red flags include clinics that assign a solo general surgeon without ENT or endocrinology support, facilities lacking a dedicated 24/7 neuro-ICU, vague pricing that excludes essential hormone testing or ICU stays, and unrealistic marketing promising complete tumor clearance or zero complication risks. To understand how patient transfers and multidisciplinary evaluations are organised, read how it works. You can submit your MRI scans for assessment and receive a comprehensive medical proposal through our free quote page.
Key questions to ask your neurosurgeon before traveling
Before confirming your surgical booking, discuss these direct questions with your prospective surgical team:
- Do you operate as a dual team with both a dedicated neurosurgeon and an ENT skull-base surgeon?
- How many endoscopic transsphenoidal pituitary operations does your surgical team perform each year?
- What is your centre's specific protocol for monitoring serum electrolytes, fluid balance, and diabetes insipidus following surgery?
- What reconstruction techniques and vascularised flaps do you use if an intraoperative CSF leak occurs?
- Will an endocrinologist assess my hormone levels before surgery and provide an adjusted discharge medication plan?
- How many days after discharge must I remain in Turkey for nasal endoscopy and flight clearance?
- What formal surgical reports, discharge summaries, and post-operative MRI discs will be supplied for my local medical team?
Hospitals with Neurosurgery in Turkey
Frequently asked questions
Pituitary tumor surgery is a specialised neurosurgical operation to remove abnormal growths from the pituitary gland at the base of the skull. Most procedures use an endoscopic transsphenoidal approach through the nasal cavity, avoiding external facial or cranial incisions to relieve pressure on the optic chiasm and normalise hormone production.
Yes, clinical evidence confirms that transsphenoidal surgery successfully relieves compression on the optic nerves in over 85% of patients with visual deficits. For hormone-secreting microadenomas, biochemical cure rates range between 70% and 85%. Tumours that have invaded lateral cavernous sinuses have lower complete clearance rates and may require adjuvant medical therapy or stereotactic radiosurgery.
Approximate costs in Turkey typically range from €7,500 to €16,000, compared with €18,000 to €35,000 in the UK and up to €85,000 in the US. The price covers pre-operative 3T MRI, neuro-navigation, the dual neurosurgical and ENT team, theatre time, intensive care, inpatient monitoring, and initial follow-up before flying home.
Before and after results are assessed on post-operative MRI scans, visual field charts, and blood hormone levels rather than cosmetic photographs. Patients with visual impairment often report sharper peripheral vision within days. Hormonal stability develops over weeks to months, and long-term surveillance imaging verifies that the tumor cavity remains clear of recurrence.
Hospital stay lasts about three to five days, including one or two days in high dependency care for hormone and fluid checks. Most patients return to light desk work within three to four weeks. Strenuous exercise, heavy lifting, and nose blowing must be avoided for six weeks to allow the skull-base repair to seal completely.
Because the operation is performed through natural nasal pathways without skin cuts, external pain is minimal. Patients usually experience mild nasal congestion, sinus pressure, and moderate headaches comparable to a sinus infection. These symptoms are managed effectively with mild prescription analgesics and typically settle significantly within one to two weeks.
When an adenoma is completely removed, relief of optic nerve compression is permanent. However, recurrence occurs in approximately 10% to 20% of cases over a ten-year period, especially with aggressive macroadenomas. Ongoing endocrine monitoring and periodic surveillance MRI scans are essential to catch any regrowth early and apply targeted secondary treatments if needed.
In specialised skull-base neurosurgery centres, transsphenoidal surgery is considered safe with a mortality rate below 0.5%. Potential complications include cerebrospinal fluid leaks, temporary or permanent diabetes insipidus, pituitary hormone deficiencies, and bleeding. Choosing an experienced multidisciplinary skull-base team with high annual case volumes substantially minimises these surgical risks.
Endoscopic transsphenoidal surgery is the primary treatment for most adenomas because it provides direct access with no brain retraction and shorter hospitalisation. Craniotomy is reserved for rare giant tumours with extensive lateral brain involvement. Stereotactic radiosurgery treats persistent microscopic remnants or recurrent margins without incisions, but takes months or years to lower hormone levels.
International patients usually stay seven to ten days in Turkey. This covers pre-operative multidisciplinary evaluations, the surgical procedure, three to five nights of inpatient hospital monitoring, nasal debridement or packing check by the ENT specialist, and blood electrolyte confirmation before the neurosurgical team clears you for your flight.
Patient stories